Table 5.

Frequencies of treatment-emergent adverse events (TEAEs)* (safety population)

Category of TEAE	Pegfilgrastim 6 mg (N = 101)	Lipegfilgrastim 6 mg (N = 101)
	n (%)	n (%)
Any TEAE	99 (98.0)	100 (99.0)
Drug-related TEAE = TEADR	26 (25.7)	28 (27.7)
Serious TEAE	7 (6.9)	3 (3.0)
Serious TEADR	1 (1.0)	1 (1.0)
Severe TEAE	35 (34.7)	26 (25.7)
Severe TEADR	2 (2.0)	1 (1.0)
Discontinued due to TEAE	2 (2.0)	3 (3.0)
Discontinued due to TEADR	1 (1.0)	0 (0)
Death	0 (0)	1 (1.0)

^*Patients could be counted in multiple categories.

TEAE treatment-emergent adverse event; TEADR treatment-emergent adverse drug reaction.